Good morning, everyone. How are you today? Getting ready for those meetings and deadlines? We relate. There is much to do here on the Pharmalot corporate campus - reading, writing, chasing down interesting people. To prepare, we are brewing that reliable cup of stimulation - our flavor today is Rain Forest Nut. Feel free to join us. And to get things started, here are some tidbits. Have a good one and stay in touch...
Bristol And Astra Diabetes Pill Faces Safety Hurdles (Bloomberg News)
Biotechs Want Faster Drug Approvals (Boston Globe)
Lilly CEO Blames Tax Laws & Immigration For Slower Innovation (Bloomberg News)
Texas Prevents Fewer Potent Drugs Prescribed To Kids (Texas Tribune)
Glaxo Ordered To Give Plaintiff Lists To United Health (Legal Intelligencer)
Too Many UK Patients Are Prescribed Risky Drugs (Pharma Times)
Abbott Labs Plant Closure Delayed (The Recorder & Times)
BioMarin To Buy Pfizer Plant In Ireland (Irish Times)
Roche Sets Up R&D Institute In France (Manufacturing.net)
Trial Of New TB Vaccine Raises Questions About Timing (Reuters)
GAO Says FDA Needs To Improve Monitoring Of Device Recalls (Reuters)
Watson To Expand Salt Lake Facility (Pharmaceutical Business Review)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr